Completed PHASE1/PHASE2 INTERVENTIONAL NCT00178945

Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain

Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Botulinum Toxin Type A (Botox) for the Treatment of Pain Associated With Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome

Sponsor: Vanderbilt University

Conditions Cervical Dystonia Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS)

Interventions Botulinum Toxin Type A

Updated 5 times since 2017 Last updated: May 27, 2016 Started: Mar 31, 2004 Completion: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS), this trial is completed. The trial is conducted by Vanderbilt University and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vanderbilt University

Data source: Vanderbilt University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States